EcoDrugPlus

Coagulation Factor Vii-Like

Ensembl ID : ENSMMDG00005019070
Gene Symbol: LOC115375219
3 Cross references
78 Possible Orthologues:

Coagulation Factor X-Like

Ensembl ID : ENSMMDG00005019165
Gene Symbol: LOC115369902
3 Cross references
240 Possible Orthologues:

Coagulation Factor Xi-Like

Ensembl ID : ENSMMDG00005004547
Gene Symbol: LOC115367301
2 Cross references
214 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSMMDG00005001256
Gene Symbol: CCDC6
3 Cross references
207 Possible Orthologues:

Collagenase 3-Like

Ensembl ID : ENSMMDG00005007389
Gene Symbol: LOC115371926
3 Cross references
306 Possible Orthologues:

Colony Stimulating Factor 1 Receptor, A

Ensembl ID : ENSMMDG00005020516
Gene Symbol: CSF1RA
1 Cross references
63 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSMMDG00005023317
Gene Symbol: CRHR1
1 Cross references
207 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSMMDG00005011749
Gene Symbol: CCND1
3 Cross references
234 Possible Orthologues:

Cyclin D1

Ensembl ID : ENSMMDG00005000547
Gene Symbol: CCND1
3 Cross references
206 Possible Orthologues:

Cyclin Dependent Kinase 1

Ensembl ID : ENSMMDG00005021864
Gene Symbol: CDK1
3 Cross references
247 Possible Orthologues:

Cyclin Dependent Kinase 2

Ensembl ID : ENSMMDG00005022622
Gene Symbol: CDK2
3 Cross references
202 Possible Orthologues:

Cyclin Dependent Kinase 4

Ensembl ID : ENSMMDG00005022373
Gene Symbol: CDK4
3 Cross references
239 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).